Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Alpa Laboratories Merger & Restructuring

Alpa Laboratories Ltd. has approved exploring the incorporation of an overseas entity in Nigeria, 'Alpa Biopharm Limited,' in partnership with Blueseal Pharmaceuticals Limited. This is in-principle only.

Source

BSE filing, NSE: ALPA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alpa Laboratories Ltd: key numbers

Share price
₹52.97
Market cap
₹111.5 Cr
Revenue (annual)
₹105.8 Cr
Net profit (annual)
₹15.01 Cr
P/E (TTM)
31.9×Sector 45.9×
Promoter holding
57.19%+0.00% QoQ
FII holding
0.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alpa Laboratories Ltd

All →

Other merger & restructuring announcements

All →